Composition and method for treating neurological disease
The present disclosure is directed to methods of treating neurological disorders in a patient such as Parkinson's disease, drug-induced extrapyramidal reactions, and/or levodopa-induced dyskinesia comprising administering to the patient once daily in the morning a pharmaceutical composition com...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
05.12.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure is directed to methods of treating neurological disorders in a patient such as Parkinson's disease, drug-induced extrapyramidal reactions, and/or levodopa-induced dyskinesia comprising administering to the patient once daily in the morning a pharmaceutical composition comprising about 50 mg to about 400 mg of extended-release amantadine or a pharmaceutically acceptable salt thereof. |
---|---|
Bibliography: | Application Number: US202017131323 |